- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06073977
Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation (PEDSGAP)
February 14, 2026 updated by: Alper Kilicaslan
Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation (PEDSGAP): A Multicentric Prospective Observational Study
This study is designed to observe the occurrence of failure or difficulty during placement of supraglottic airway devices (SGAs) and its associated risk factors in pediatric patients.
Despite wide use in pediatric practice, not much is known related to problems during SGA insertion unlike adults.
The main information regarding pediatric SGA comes from either small comparative studies or retrospective studies reporting increased risk of failure.
Thus the main aim of this prospective, multicentric, observational study is to determine the incidence of "difficult" or "failed" SGA placement in children and clarify the possible risk factors for difficulty.
Study Overview
Status
Completed
Conditions
Detailed Description
Inclusion criteria
- 1- 12 years old peditatric patients
- ASA class I- III
- Scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance
- Planned surgery under general anesthesia with SGA
- Patients whose legal guardians provide informed consent
Exclusion criteria
- Refusal to participate in the study.
- Inability of patient or parents to understand the study or consent process
- Orotracheal intubation requirement
- Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
- Increased risk of regurgitation or aspiration
- Emergency surgeries
- Requirement for intensive care follow-up after the surgery
Study Type
Observational
Enrollment (Actual)
3750
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Asli Dönmez
-
Istanbul, Turkey (Türkiye)
- Emre Sertaç Bingül
-
Izmir, Turkey (Türkiye)
- Gaye Aydin
-
Kayseri, Turkey (Türkiye)
- Sibel Seckin Pehlivan
-
Konya, Turkey (Türkiye)
- Necmettin Erbakan University
-
Trabzon, Turkey (Türkiye)
- Sedat Saylan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
1- 12 years old peditatric patients scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance
Description
Inclusion Criteria:
- 1- 12 years old peditatric patients
- ASA class I- III
- Planned surgery under general anesthesia with supraglottic airway
- Patients whose legal guardians provide informed consent
Exclusion Criteria:
- Refusal to participate in the study
- Inability of patient or parents to understand the study or consent process
- Orotracheal intubation requirement
- Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
Increased risk of regurgitation or aspiration
- Emergency surgeries
- Requirement for intensive care follow-up after the surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The incidence of difficulty in supraglottic airway device(SGA) placement
Time Frame: Immediately after the attempt of insertion and up to the end of the surgery
|
Difficulty in placing SGA is defined as follows: SGA insertion that requires more than one attempt,need for a change the size or type of SGA,desatutaion (SpO2<93%), disrupted capnography,high airway pressure (>25 cmH2O of peak pressure)
|
Immediately after the attempt of insertion and up to the end of the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Risk factors for pediatric difficult SGA placement
Time Frame: At the beginning of anesthesia
|
Possible risk factors related with failure and difficulty listed as:experience of the anaesthetist , presence of history of asthma/pneumoniae,presence of craniofascial anomalies, use of neuromuscular blocking agent, type and placement technique of SGA
|
At the beginning of anesthesia
|
|
The incidence of complications related to SGA insertion
Time Frame: Up to 24 hours after surgery
|
The incidence of adverse events including laryngospasm, desaturation bronchospasm, stridor, regurgitation bucking, airway trauma and postoperative complications including difficult weaning, cough, stridor, vomiting, dysfagia, dysphonia
|
Up to 24 hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Alper Kilicaslan, Necmettin Erbakan Universty Medical Faculty
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2023
Primary Completion (Actual)
March 30, 2024
Study Completion (Actual)
April 1, 2024
Study Registration Dates
First Submitted
September 26, 2023
First Submitted That Met QC Criteria
October 5, 2023
First Posted (Actual)
October 10, 2023
Study Record Updates
Last Update Posted (Actual)
February 17, 2026
Last Update Submitted That Met QC Criteria
February 14, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 2023/4546
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children
-
Duke UniversityBoston Children's Hospital; Agency for Healthcare Research and Quality (AHRQ)CompletedChildren, Only | Children and Youth With Special Healthcare NeedsUnited States
-
Elizabeth Glaser Pediatric AIDS FoundationUnited States Agency for International Development (USAID); Biomedical Research... and other collaboratorsTerminatedOrphans, Children, Adolescents | Vulnerable Children, Adolescents | Community-basedZimbabwe
-
National Institute of Mental Health (NIMH)RecruitingHealthy Children | Children With Neurodevelopmental Disorders | Children With Neuropsychiatric Disorders | Children With Behavioral SyndromesUnited States
-
Centre Hospitalier St AnneCentre National de la Recherche Scientifique, France; Université Paris CitéNot yet recruitingChildren | Typical Development | FRENCH STUDY | Children Behavior Problem | Typical Preschoolers Who Can Not Zipper | Typically Developing Children Ages 3 to 6
-
University of PaviaNot yet recruiting
-
Georgetown UniversityPenn State UniversityCompleted
-
Sheffield Children's NHS Foundation TrustUniversity of Sheffield; Sheffield Hallam UniversityCompletedChildrenUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedChildrenUnited States